In our study, injection of TNBC cells with either knockdown or overexpression of PCSK9 into NOD/SCID mice resulted in significant decreases and increases in orthotopic and metastatic tumor sizes compared to those in the control group. This evidence concerns the gene PCSK9 and neoplasm.